Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 May 29:21:e00820.
doi: 10.1016/j.idcr.2020.e00820. eCollection 2020.

Isolated severe thrombocytopenia in a patient with COVID-19: A case report

Affiliations
Case Reports

Isolated severe thrombocytopenia in a patient with COVID-19: A case report

Sara Sadr et al. IDCases. .

Abstract

COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such as hematopoietic, neurological and the immune system. In this report, we described a case of a COVID-19 patient who presented with no pulmonary involvement but severe thrombocytopenia. She suffered from headache and malaise with no respiratory symptoms, fever or chills. Chest radiological imaging was unremarkable but, the laboratory results showed significant thrombocytopenia associated with relatively decreased lymphocytes. Based on her high-risk work environment, a reverse transcription polymerase chain reaction (RT-PCR) test was performed and SARS-CoV-2 RNA was detected in the nasopharyngeal swab. Complete blood count (CBC) of patient was re-checked during admission and platelet count showed rising trend up to normal levels. A narrow diagnostic approach where only febrile patients with pulmonary symptoms are evaluated for a COVID-19 diagnosis will result in many missed diagnoses; so it is important that physicians are familiar with atypical and rare presentations of COVID-19, such as isolated thrombocytopenia.

Keywords: Coronavirus disease 2019 (COVID-19); Lymphopenia; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Thrombocytopenia.

PubMed Disclaimer

References

    1. World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report– 72 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
    1. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet (London, England) 2020;395:470–473. - PMC - PubMed
    1. Henry B.M., Green M.S., Han H., Luo Q., Mo F., Long L. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. - PMC - PubMed
    1. Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Bondi. Zoccai G. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020;75:2352–2371. - PMC - PubMed
    1. Zhang J., Dong X., Cao Y., Yuan Y., Yang Y., Yan Y. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;00:1–12. - PubMed

Publication types

LinkOut - more resources